1h Free Analyst Time
The cancer supportive care market is forecasted to grow by USD 6.25 billion during 2023-2028, accelerating at a CAGR of 4.3% during the forecast period. The report on the cancer supportive care market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer cases, many side effects associated with cancer treatment, and untapped potential in developing countries.
The cancer supportive care market is segmented as below:
By Therapeutic Area
- Chemotherapy-induced anemia
- Chemotherapy-induced neutropenia
- Cancer pain
- CINV
- Others
By Distribution Channel
- Hospitals pharmacies
- Drug stores and retail pharmacies
- Online providers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cancer supportive care market covers the following areas:
- Cancer Supportive Care Market sizing
- Cancer Supportive Care Market forecast
- Cancer Supportive Care Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapeutic Area
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global cancer supportive care market: Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson Services Inc., Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of biosimilars in cancer-associated treatment."
According to the report, one of the major drivers for this market is the growing prevalence of cancer cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- Baxter International Inc.
- Bayer AG
- Daiichi Sankyo Co. Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Helsinn Healthcare SA
- Heron Therapeutics Inc.
- Johnson and Johnson Services Inc.
- Kyowa Kirin Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Purdue Pharma LP
- RELIEF THERAPEUTICS Holding SA
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
